![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_0f4a04984ecf34abfddd13f4de2d16f4.svg) | 1-[(trans-4-Aminocyclohexyl)methyl]-N-Butyl-3-(4-Fluorophenyl)-1h-Pyrazolo[3,4-D]pyrimidin-6-Amine | IC50 | 2.9 [1], 141.0 [2] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_0f4a04984ecf34abfddd13f4de2d16f4.svg) | 1-[(trans-4-Aminocyclohexyl)methyl]-N-Butyl-3-(4-Fluorophenyl)-1h-Pyrazolo[3,4-D]pyrimidin-6-Amine | Ki | 4.3 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_ff95bbd79c6563429a07b3e2e70ebe12.svg) | 2-(2-Hydroxyethylamino)-6-(3-chloroanilino)-9-isopropylpurine | IC50 | 11000.0 [1], 11300.0 [2] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_473fafde5f65865ea7207466037e5614.svg) | 4-[2-(Butylamino)-5-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]pyrrolo[2,3-d]pyrimidin-7-yl]cyclohexan-1-ol | IC50 | 0.46 [1], 0.74 [2], 2.7 [3] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_1b4e021e73e18c4d77e61a14bc0121f0.svg) | 4-[5-[4-[(4-Methyl-1,4-diazepan-1-yl)methyl]phenyl]-2-[[(2S)-pentan-2-yl]amino]pyrrolo[2,3-d]pyrimidin-7-yl]cyclohexan-1-ol | IC50 | 0.6 [1], 2.4 [2], 13.8 [3] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_e7ecb06887875f4d78baf892d82c33a5.svg) | Bms-777607 | IC50 | 14.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_21b312da3a0ca2e00016eafda80097df.svg) | Bemcentinib | IC50 | 15.0 [1], 700.0 [2] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_792fb9fb89419c9228e5974ac890efb7.svg) | Unii-T7755XP5Y6 | IC50 | 1.1 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_8fb35f27122721b8a0a25b7d7119f63d.svg) | 4-[[2-(Butylamino)-5-[5-(morpholin-4-ylmethyl)pyridin-2-yl]pyrimidin-4-yl]amino]cyclohexan-1-ol | IC50 | 1.7 [1], 9.8 [2] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_d99325f173e26d7db80592089b850e5b.svg) | 2-(Butylamino)-4-[(4-hydroxycyclohexyl)amino]-N-[(4-imidazol-1-ylphenyl)methyl]pyrimidine-5-carboxamide | IC50 | 4.3 [1], 22.0 [2] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_b9bacc89876e00377722328a91c61513.svg) | 1-[(4-Aminocyclohexyl)methyl]-N-methyl-3-(4-piperazin-1-ylphenyl)pyrazolo[3,4-d]pyrimidin-6-amine | IC50 | 18.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_6a63a58acb1ce160573a1db1434b1f6d.svg) | 1-[(4-Aminocyclohexyl)methyl]-N-methyl-3-phenylpyrazolo[3,4-d]pyrimidin-6-amine | IC50 | 56.0 [1], 180.0 [2] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_9718ee011ec2cba8b22955bd0f317eaa.svg) | 1-[(4-Aminocyclohexyl)methyl]-N-butyl-3-(6-piperazin-1-ylpyridin-3-yl)pyrazolo[3,4-d]pyrimidin-6-amine | IC50 | 1.8 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_9718ee011ec2cba8b22955bd0f317eaa.svg) | 1-[(4-Aminocyclohexyl)methyl]-N-butyl-3-(6-piperazin-1-ylpyridin-3-yl)pyrazolo[3,4-d]pyrimidin-6-amine | Ki | 2.7 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_fce96ea01d5492a118d9af3438a0fd30.svg) | 1-[(4-Aminocyclohexyl)methyl]-N-butyl-3-(4-piperazin-1-ylphenyl)pyrazolo[3,4-d]pyrimidin-6-amine | IC50 | 0.25 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_fce96ea01d5492a118d9af3438a0fd30.svg) | 1-[(4-Aminocyclohexyl)methyl]-N-butyl-3-(4-piperazin-1-ylphenyl)pyrazolo[3,4-d]pyrimidin-6-amine | Ki | 0.73 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_b3e4105279af1744cdd028b472504684.svg) | 1-[(4-Aminocyclohexyl)methyl]-N-(3-phenylpropyl)-3-(6-piperazin-1-ylpyridin-3-yl)pyrazolo[3,4-d]pyrimidin-6-amine | IC50 | 0.76 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_b3e4105279af1744cdd028b472504684.svg) | 1-[(4-Aminocyclohexyl)methyl]-N-(3-phenylpropyl)-3-(6-piperazin-1-ylpyridin-3-yl)pyrazolo[3,4-d]pyrimidin-6-amine | Ki | 1.4 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_2411c894a673640609b624e7332a3d93.svg) | 1-[(4-Aminocyclohexyl)methyl]-N-(3-phenylpropyl)-3-(4-piperazin-1-ylphenyl)pyrazolo[3,4-d]pyrimidin-6-amine | IC50 | 0.15 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_2411c894a673640609b624e7332a3d93.svg) | 1-[(4-Aminocyclohexyl)methyl]-N-(3-phenylpropyl)-3-(4-piperazin-1-ylphenyl)pyrazolo[3,4-d]pyrimidin-6-amine | Ki | 0.56 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_ffde2368846e99fcfbf9ca2c88012152.svg) | 4-[[6-(Methylamino)-3-phenylpyrazolo[3,4-d]pyrimidin-1-yl]methyl]cyclohexan-1-ol | IC50 | 200.0 [1], 210.0 [2] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_3d19b85c5332d90b097a2f7b235c03c2.svg) | 1-[(4-Aminocyclohexyl)methyl]-3-(4-fluorophenyl)-N-(3-phenylpropyl)pyrazolo[3,4-d]pyrimidin-6-amine | IC50 | 3.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_3d19b85c5332d90b097a2f7b235c03c2.svg) | 1-[(4-Aminocyclohexyl)methyl]-3-(4-fluorophenyl)-N-(3-phenylpropyl)pyrazolo[3,4-d]pyrimidin-6-amine | Ki | 2.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_71acea9a6dfc0e4dac7865946b73384c.svg) | Paclitaxel | IC50 | 4900.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_1d5eba4b4bb57896dda18b1604bab021.svg) | Staurosporine | IC50 | 83.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_c77eb69f87d46b4d00314a6bfb851cf8.svg) | Crizotinib | IC50 | 100.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_7e037c210cad9a24b0c9ce116fb5b97c.svg) | CID 53469448 | IC50 | 474.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_fa37ae125bcd4e6df1af4be57fbea491.svg) | 1-Cyclopropyl-3-(3-(5-(morpholinomethyl)-1H-benzo[d]imidazol-2-yl)-1H-pyrazol-4-yl)urea | IC50 | 1.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_179888a64edb35ddee0be2a16e245b3a.svg) | MK-2461 | IC50 | 24.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_836d58634120a742d63c1602f26addff.svg) | CID 59604787 | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_e07c8cd6f81fa23b777a36d7d9709688.svg) | 4-Tert-Butyl-N-[6-(1h-Imidazol-1-Yl)imidazo[1,2-A]pyridin-2-Yl]benzamide | IC50 | 6456.54 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_3e70e51b426b206601dadb33b22bbf88.svg) | 2-Amino-N-[3-[[5-chloro-4-(2-propan-2-ylsulfonylanilino)pyrimidin-2-yl]amino]phenyl]acetamide | IC50 | 1000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_f046ae8812a77e5cb35fd8b53bebf05d.svg) | Ripk1-IN-7 | IC50 | 29.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_b9c2c7255ce57fac793a695eb4cd5f8c.svg) | N-[2-(4-Methoxyanilino)-4-quinazolinyl]-N-methylamine | IC50 | 2250.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_51153882d3ab9f3566d96aeaf5c3eeab.svg) | 6-(2,4-Difluorophenyl)sulfonyl-2-(1H-indol-5-ylamino)-8-methylpyrido[2,3-d]pyrimidin-7-one | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_3a1e56d5d51d2c234a4be70e7f61f632.svg) | N-(4-Methoxyphenyl)-4-(morpholin-4-yl)quinazolin-2-amine | IC50 | 2060.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_0ca3e879b155ef6af0c4654d7cf4d922.svg) | 4-(Cyclopentylamino)-2-[(2-methoxyphenyl)methylamino]-N-[3-(2-oxopyrrolidin-1-yl)propyl]pyrimidine-5-carboxamide | IC50 | 4680.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_be6f7f8b06f86a492aec83c8596cec64.svg) | 4-(Cyclopentylamino)-2-[(2,5-dichlorophenyl)methylamino]-N-[3-(2-oxopyrrolidin-1-yl)propyl]pyrimidine-5-carboxamide | IC50 | 1920.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_25dd0b4f2746e9aaee1e0d2ca0362bc9.svg) | 4-(Cyclopentylamino)-2-[(2,5-dichlorophenyl)methylamino]-N-[3-(2-oxo-1,3-oxazolidin-3-yl)propyl]pyrimidine-5-carboxamide | IC50 | 775.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_b48ec436f5a292f18e8fde779fde6c11.svg) | (7S)-7-Amino-N-[(4-fluorophenyl)methyl]-8-oxo-2,9,16,18,21-pentazabicyclo[15.3.1]henicosa-1(21),17,19-triene-20-carboxamide | IC50 | 4.4 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_7cb6d5f17bcd9bbe162ed7e4e037e57d.svg) | N-(4-Fluorophenyl)-4-(morpholin-4-yl)quinazolin-2-amine | IC50 | 30000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_5b5057f07ba36d969b42e83280bc9205.svg) | 2-[3-(3-Piperidin-4-ylpropoxy)phenyl]-N-[4-(1H-pyrrolo[2,3-b]pyridin-3-yl)-1,3-thiazol-2-yl]acetamide | Ki | 2000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_61551f1612b1d03b33f689e3fdae85ae.svg) | 2-[3-(Methanesulfonamido)phenyl]-N-[4-(1H-pyrrolo[2,3-b]pyridin-3-yl)-1,3-thiazol-2-yl]acetamide | Ki | 2000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_ca08212b911ff77e7266240517191aaf.svg) | 4-[5-[4-(Morpholin-4-ylmethyl)phenyl]-2-[[(2S)-pentan-2-yl]amino]pyrrolo[2,3-d]pyrimidin-7-yl]cyclohexan-1-ol | IC50 | 3.2 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_f0a37a03c0093e032226113e49c1a05e.svg) | 4-[5-[3-[(4-Methylpiperazin-1-yl)methyl]phenyl]-2-[[(2S)-pentan-2-yl]amino]pyrrolo[2,3-d]pyrimidin-7-yl]cyclohexan-1-ol | IC50 | 4.9 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_71c7e087d633f4e19f7daec405e54563.svg) | 4-[2-(Butylamino)-5-[4-(piperidin-4-ylamino)phenyl]pyrrolo[2,3-d]pyrimidin-7-yl]cyclohexan-1-ol | IC50 | 5.2 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_0d98b4b226593ed7c0a8defd998755d1.svg) | 4-[5-[4-[(4-Methylpiperazin-1-yl)methyl]phenyl]-2-[[(2R)-pentan-2-yl]amino]pyrrolo[2,3-d]pyrimidin-7-yl]cyclohexan-1-ol | IC50 | 22.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_e392d737a0df7005ece96281df7cbe82.svg) | 4-[5-[4-[(4-Methylpiperazin-1-yl)methyl]phenyl]-2-(pentan-2-ylamino)pyrrolo[2,3-d]pyrimidin-7-yl]cyclohexan-1-ol | IC50 | 3.5 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_3f6518b869b2986e22f8da030a770263.svg) | 4-[2-[[(2S)-Heptan-2-yl]amino]-5-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]pyrrolo[2,3-d]pyrimidin-7-yl]cyclohexan-1-ol | IC50 | 3.6 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_69b40bac9011556cd6dce5403e2715b4.svg) | 4-[5-[4-[(4-Methylpiperazin-1-yl)methyl]phenyl]-2-[[(2S)-pentan-2-yl]amino]pyrrolo[2,3-d]pyrimidin-7-yl]cyclohexan-1-ol | IC50 | 4.3 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_9c7d6e0a23eb7bfa3e5ed7b31b6be340.svg) | 4-[5-[4-[(4-Methylpiperazin-1-yl)methyl]phenyl]-2-[[(2S)-1,1,1-trifluoropentan-2-yl]amino]pyrrolo[2,3-d]pyrimidin-7-yl]cyclohexan-1-ol | IC50 | 1068.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_d05db671c729e40f8875ed38981dee9f.svg) | 4-[2-(2-Methylbutylamino)-5-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]pyrrolo[2,3-d]pyrimidin-7-yl]cyclohexan-1-ol | IC50 | 5.2 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_07ab18d3db5057f9358cde6058c8e247.svg) | 4-[2-(2-Ethylbutylamino)-5-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]pyrrolo[2,3-d]pyrimidin-7-yl]cyclohexan-1-ol | IC50 | 19.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_fcc4aed6b7459f36c0512afd232a74e6.svg) | 4-[5-[4-[(4-Methylpiperazin-1-yl)methyl]phenyl]-2-[[(2R)-1,1,1-trifluoropentan-2-yl]amino]pyrrolo[2,3-d]pyrimidin-7-yl]cyclohexan-1-ol | IC50 | 20.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_ec209bc088d0fb656e0f2c34c5fe1073.svg) | 4-[2-[[(2S)-Hexan-2-yl]amino]-5-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]pyrrolo[2,3-d]pyrimidin-7-yl]cyclohexan-1-ol | IC50 | 2.6 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_fb29fb1dee00965bf330db406b7e4be1.svg) | 4-[5-[4-[[2-(Diethylamino)ethylamino]methyl]phenyl]-2-[[(2S)-pentan-2-yl]amino]pyrrolo[2,3-d]pyrimidin-7-yl]cyclohexan-1-ol | IC50 | 2.5 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_f8f0852d6a47a15276fb53b646bc7a21.svg) | 4-[2-[[(2S)-Pentan-2-yl]amino]-5-[4-(piperidin-4-ylamino)phenyl]pyrrolo[2,3-d]pyrimidin-7-yl]cyclohexan-1-ol | IC50 | 4.9 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_448f1b5de31eb90a36c6fc2eb55d6cc9.svg) | 4-[5-[4-(Cyclohexylamino)phenyl]-2-[[(2S)-pentan-2-yl]amino]pyrrolo[2,3-d]pyrimidin-7-yl]cyclohexan-1-ol | IC50 | 72.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_97d47df88b3c08bf705bee1b72f3a8b2.svg) | 4-[5-[4-(7-Azabicyclo[2.2.1]heptan-7-ylmethyl)phenyl]-2-[[(2S)-pentan-2-yl]amino]pyrrolo[2,3-d]pyrimidin-7-yl]cyclohexan-1-ol | IC50 | 2.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_d828f8c0f29b9de121301416f4615bf1.svg) | 4-[5-[2-Fluoro-4-(4-methylpiperazin-1-yl)sulfonylphenyl]-2-[[(2S)-pentan-2-yl]amino]pyrrolo[2,3-d]pyrimidin-7-yl]cyclohexan-1-ol | IC50 | 3.5 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_cb5f0d1b2973f214dbee47024fa34cd7.svg) | 4-[2-(Butylamino)-5-(4-phenoxyphenyl)pyrrolo[2,3-d]pyrimidin-7-yl]cyclohexan-1-ol | IC50 | 78.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_397f9163ba8122b083e9cbde37ddfde5.svg) | 4-[2-(Butylamino)-5-[4-(4-methylpiperazin-1-yl)phenyl]pyrrolo[2,3-d]pyrimidin-7-yl]cyclohexan-1-ol | IC50 | 3.5 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_0d0dd40987e4500a15c5e6b21d467eea.svg) | 2-Fluoro-4-[8-fluoro-3-(quinolin-6-ylmethyl)imidazo[1,2-a]pyridin-6-yl]-N-methylbenzamide | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_b6faf72dfa81ac6f5cbbee7518dcb7f6.svg) | 4-[6-(Benzylamino)imidazo[1,2-B]pyridazin-3-Yl]benzonitrile | IC50 | 5400.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_07f245678e6fcc2d52455f8c1a6544d0.svg) | 2-[4-[4-[6-[(2R)-2-(3-Fluorophenyl)pyrrolidin-1-yl]imidazo[1,2-b]pyridazin-3-yl]pyridin-2-yl]piperazin-1-yl]acetic acid | IC50 | 4700.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_cadcfe40c75731fb4d071e8664de359c.svg) | 1-[4-[6-[(2R)-2-(3-Fluorophenyl)pyrrolidin-1-yl]imidazo[1,2-b]pyridazin-3-yl]pyridin-2-yl]piperidin-4-ol | IC50 | 5100.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_574a45544e8cb1fe403e1c65b194818e.svg) | 6-(1-Methylpyrazol-4-yl)-2-[[3-[[5-(1-methylpyrazol-4-yl)pyrimidin-2-yl]amino]phenyl]methyl]pyridazin-3-one | IC50 | 1000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_da2971ffc7be52925e09187e7d5644e5.svg) | 2-N-(4-Methoxyphenyl)-2-N,4-N-dimethylquinazoline-2,4-diamine | IC50 | 10200.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_3c7b9edbd18e73311ac423fb8d0c9be6.svg) | 3-[[2-(4-Aminoanilino)quinazolin-4-yl]amino]propan-1-ol | IC50 | 30000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_e7b343e012b0a82c39dc07998ba0a7cb.svg) | 2-N-(4-Methoxyphenyl)-2-N-methyl-4-N-propylquinazoline-2,4-diamine | IC50 | 1840.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_2c9b63b80b2ddc06c112556f1d2e2534.svg) | 4-[[4-(Cyclopentylamino)quinazolin-2-yl]amino]benzonitrile | IC50 | 30000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_39252c7f855858c6a152e19dd8593ccb.svg) | 2-N-(4-Aminophenyl)-4-N-cyclopentylquinazoline-2,4-diamine | IC50 | 7270.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_9c7447e348a2edf4bd1f1ee77460366a.svg) | 4-[[4-(3-Hydroxypropylamino)quinazolin-2-yl]amino]benzonitrile | IC50 | 1720.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_70f02ccd81e4b3d1fcda1acf9d4fe83d.svg) | 4-N-(4-Morpholin-4-ylquinazolin-2-yl)benzene-1,4-diamine | IC50 | 30000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_afaf7e9a6e5772950492325feac81062.svg) | 2-N-(4-Methoxyphenyl)-2-N-methyl-4-N-(oxan-4-ylmethyl)quinazoline-2,4-diamine | IC50 | 30000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_22dc8af1f0aa623ae6d0bfca2ebbb38f.svg) | 4-N-Cyclopentyl-2-N-(4-methoxyphenyl)-2-N-methylquinazoline-2,4-diamine | IC50 | 1140.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_282d013ce36e3982496feb384b1ad9c1.svg) | 3-[[2-(4-Methoxy-N-methylanilino)quinazolin-4-yl]amino]propan-1-ol | IC50 | 2010.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_4644b0f10cdda018045c8199bb5756f7.svg) | N-(4-Methoxyphenyl)-N-methyl-4-morpholin-4-ylquinazolin-2-amine | IC50 | 30000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_e021781d73f737111b72f54323b55bbc.svg) | 6-[Difluoro-[6-(4-fluorophenyl)-[1,2,4]triazolo[4,3-b][1,2,4]triazin-3-yl]methyl]quinoline | IC50 | 1000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_f321563f2050b22443b36ad392046691.svg) | 18-[4-[(4-Methylpiperazin-1-yl)methyl]phenyl]-1,13,15,21-tetrazatricyclo[12.5.2.017,20]henicosa-14,16,18,20-tetraen-5-ol | IC50 | 1.8 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_9c21d098deec5e6c52185677ffff5b57.svg) | 19-Pyridin-2-yl-1,14,16,22-tetrazatricyclo[13.5.2.018,21]docosa-15,17,19,21-tetraen-6-ol | IC50 | 54.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_6efa5aa571be54c31c8f10827b6a796b.svg) | 19-(4-Fluorophenyl)-1,14,16,22-tetrazatricyclo[13.5.2.018,21]docosa-15,17,19,21-tetraen-6-ol | IC50 | 150.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_99e4e4fd9611f62be4f84ef6cfbabe51.svg) | (6S)-6-Amino-20-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]-1,8,15,17,23-pentazatricyclo[14.5.2.019,22]tricosa-16,18,20,22-tetraen-7-one | IC50 | 2.2 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_3d9e0bc8095fe13405486889dde3d844.svg) | 19-(4-Methoxyphenyl)-1,14,16,22-tetrazatricyclo[13.5.2.018,21]docosa-15,17,19,21-tetraen-6-ol | IC50 | 86.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_89097c210eadebcd7eba31bc2ccf5b2a.svg) | 19-Pyridin-3-yl-1,14,16,22-tetrazatricyclo[13.5.2.018,21]docosa-15,17,19,21-tetraen-6-ol | IC50 | 13.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_5e3b26f4e6680b624c8728fb2dda19b2.svg) | 19-[4-[(4-Methylpiperazin-1-yl)methyl]phenyl]-1,14,16,22-tetrazatricyclo[13.5.2.018,21]docosa-15,17,19,21-tetraen-6-ol | IC50 | 3.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_391d72f717d1d073f621f054573b77ee.svg) | 17-[4-[(4-Methylpiperazin-1-yl)methyl]phenyl]-1,12,14,20-tetrazatricyclo[11.5.2.016,19]icosa-13,15,17,19-tetraen-6-ol | IC50 | 8.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_4cdc999f5b9a5c71f981787f87466777.svg) | 19-(Oxan-4-yl)-1,14,16,22-tetrazatricyclo[13.5.2.018,21]docosa-15,17,19,21-tetraen-6-ol | IC50 | 94.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_84406f33252ba2ecee2f206a4d3b48c0.svg) | N-[4-(6-Hydroxy-1,14,16,22-tetrazatricyclo[13.5.2.018,21]docosa-15,17,19,21-tetraen-19-yl)phenyl]morpholine-4-carboxamide | IC50 | 30.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_e573219e22075aec56611920b5c1c117.svg) | 19-(3-Methoxyphenyl)-1,14,16,22-tetrazatricyclo[13.5.2.018,21]docosa-15,17,19,21-tetraen-6-ol | IC50 | 160.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_9e0d110e5c3728402277601f01fe0aaf.svg) | [4-(6-Hydroxy-1,14,16,22-tetrazatricyclo[13.5.2.018,21]docosa-15,17,19,21-tetraen-19-yl)phenyl]-morpholin-4-ylmethanone | IC50 | 8.1 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_efa67826d549f5fe42a8ebb13f352ae3.svg) | 19-Phenyl-1,14,16,22-tetrazatricyclo[13.5.2.018,21]docosa-15,17,19,21-tetraen-6-ol | IC50 | 140.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_e07833fb6bbcb26e09796569c62bc2e4.svg) | 18-[4-[(4-Methylpiperazin-1-yl)methyl]phenyl]-1,13,15,21-tetrazatricyclo[12.5.2.017,20]henicosa-14,16,18,20-tetraen-6-ol | IC50 | 4.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_874118ef07efeb184a8861f8f7d18e0d.svg) | 19-(2-Methoxyphenyl)-1,14,16,22-tetrazatricyclo[13.5.2.018,21]docosa-15,17,19,21-tetraen-6-ol | IC50 | 170.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_d31156660b9b5f8aa1f68804b0626304.svg) | 19-[4-[(4-Methylpiperazin-1-yl)methyl]phenyl]-1,14,16,22-tetrazatricyclo[13.5.2.018,21]docosa-15,17,19,21-tetraen-5-ol | IC50 | 9.6 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_5df64f7da6b5bea0970c7d60f44e71a7.svg) | 16-[4-[(4-Methylpiperazin-1-yl)methyl]phenyl]-1,11,13,19-tetrazatricyclo[10.5.2.015,18]nonadeca-12,14,16,18-tetraen-5-ol | IC50 | 4.1 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_db2462e9c8f772c42accf349f478e852.svg) | 20-[4-[(4-Methylpiperazin-1-yl)methyl]phenyl]-1,15,17,23-tetrazatricyclo[14.5.2.019,22]tricosa-16,18,20,22-tetraen-7-ol | IC50 | 3.1 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_7dca3992f1283c1998a2e8f1d7ec33fb.svg) | 16-[4-[(4-Methylpiperazin-1-yl)methyl]phenyl]-1,6,11,13,19-pentazatricyclo[10.5.2.015,18]nonadeca-12,14,16,18-tetraen-5-one | IC50 | 65.0 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_3d38eb673c9fa6ac01e8313ea9ebded9.svg) | 18-[4-[(4-Methylpiperazin-1-yl)methyl]phenyl]-1,13,15,21-tetrazatricyclo[12.5.2.017,20]henicosa-14,16,18,20-tetraen-7-ol | IC50 | 4.1 [1] |
![](https://images.aatbio.com/dataset/ic50/proto-oncogene-tyrosine-protein-kinase-mer_e7e8a8958ceeb49a12a0397911119dd5.svg) | (5S)-5-Amino-19-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]-1,7,14,16,22-pentazatricyclo[13.5.2.018,21]docosa-15,17,19,21-tetraen-6-one | IC50 | 17.0 [1] |